U.S. Mortgage REITs Stock News

How GlobalFoundries' Latest Numbers Set the Stage for the Next Chapter GlobalFoundries (GFS) has just posted its FY 2025 first half results, with revenue of US$3.3 billion and basic EPS of US$0.79, against a backdrop of recent trailing 12 month losses and a current share price of US$48.74. The company has seen revenue move from US$3.2 billion in the first half of 2024 to US$3.3 billion in the first half of 2025, while EPS shifted from US$0.52 to US$0.79 over the same periods. This sets up a...

RingCentral, Inc. (NYSE: RNG) was recently added to the S&P SmallCap 600, the S&P 600 Information Technology sector index, and the broader S&P Composite 1500, following its replacement of Hillenbrand Inc. after that company’s pending acquisition by Lone Star Funds. This index inclusion broadens RingCentral’s exposure to institutional investors and index-tracking funds, potentially increasing trading liquidity and embedding the stock more deeply into benchmarked portfolios. With RingCentral...

Target (NYSE:TGT) is overhauling its executive ranks under new CEO Michael Fiddelke, including 500 job cuts tied to workforce restructuring. Cara Sylvester has been appointed chief merchandising officer and Lisa Roath has been named chief operating officer. The company is putting more emphasis on in store experience and merchandising, with added investment in store level staffing and guest service. The leadership reshuffle and headcount reduction focus on corporate and supply chain roles,...

Angi FY 2025 earnings snapshot Angi (ANGI) has wrapped up FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.17, alongside net income of US$7.2 million, putting a cleaner set of numbers in front of investors. The company has seen quarterly revenue move from US$296.7 million in Q3 2024 to US$245.9 million in Q1 2025 and US$240.8 million in Q4 2025, while basic EPS has ranged from US$0.71 in Q3 2024 to US$0.30 in Q1 2025 and US$0.17 in the latest quarter. This gives a...

If you are wondering whether G-III Apparel Group is attractively priced today, you are not alone. This article is here to unpack what the current share price might be telling you about value. The stock last closed at US$30.15, with returns of 0.4% over the past 30 days, 2.2% year to date and an 87.4% gain across 3 years, while the 1 year return sits close to flat at a 0.2% decline. Recent news around G-III Apparel Group has focused on its position in the apparel and consumer durables space...

Dover (DOV) just paired its fourth quarter and full year 2025 earnings with fresh 2026 guidance, giving you new data on revenue, earnings per share expectations, and how management sees the business. See our latest analysis for Dover. The latest guidance and earnings update have arrived after a strong run in the share price, with Dover’s 30 day share price return of 14.56% and 90 day return of 28.08% contributing to a 5 year total shareholder return of 106.04%. This suggests momentum has been...

Inspire Medical Systems has reported its full-year 2025 results, with sales rising to US$911.98 million and net income reaching US$145.42 million, driving basic earnings per share from continuing operations to US$4.95, up from US$1.80 a year earlier. The sharp improvement in profitability and earnings came after analysts had recently turned more cautious on near-term quarterly performance, highlighting a gap between expectations and how efficiently the business converted higher revenue into...

Why DICK'S Sporting Goods (DKS) is back in focus DICK'S Sporting Goods (DKS) is reshaping its outdoor footprint by closing Moosejaw stores and cutting back Public Lands locations, while recent store expansion and same store sales performance keep investor attention on the stock. See our latest analysis for DICK'S Sporting Goods. The reshaping of DICK'S outdoor concepts comes as the share price sits at US$204.41, with a 1-day share price return of 2.30% contrasting with a 30-day share price...

Exelixis (EXEL) has wrapped up FY 2025 with fourth quarter revenue of US$598.7 million and basic EPS of US$0.92, supported by trailing 12 month revenue of about US$2.3 billion and EPS of US$2.88 that sit alongside a higher net profit margin than a year ago. The company has seen quarterly revenue move from US$566.8 million and EPS of US$0.49 in Q4 2024 to US$598.7 million and US$0.92 in Q4 2025, while trailing net profit margin has stepped up from 24% to 33.7%. This sets up a story where...

In early February 2026, NIO Inc. reported record January deliveries of 27,182 vehicles across its NIO, ONVO and FIREFLY brands, issued guidance for a fourth-quarter 2025 operating profit between RMB 200 million (about US$29 million) and RMB 700 million (about US$100 million), and recalled 246,229 vehicles to fix a safety-related software issue via free updates. This mix of rapid delivery growth, a first projected quarterly profit and the largest software-based recall by a Chinese EV maker...

In early February 2026, Similarweb launched AI Studio, an enterprise AI intelligence platform that layers conversational chat, deep research, and auto-generated dashboards on top of its extensive digital market data covering 100 million websites, billions of keywords, millions of apps and companies, and hundreds of millions of SKUs. By pairing specialized AI agents with its proprietary digital intelligence, AI Studio aims to compress hours of competitive analysis and market research into...

In recent months, Constellation Brands reported improving beer volume trends and highlighted new price-pack innovations, such as 12-packs and value-brand tests, while management remained cautious given the still-volatile demand backdrop. At the same time, fresh 13F filings showed several high-profile institutional investors increasing or maintaining sizable positions, underscoring confidence in the company’s premium portfolio, pricing power, and cash generation focus. Now we’ll explore how...

MasTec stock: recent performance and context MasTec (MTZ) has been on many investors’ screens after a strong recent run, with the share price at $264.99 and total return figures over the past year and past 3 months drawing closer attention. See our latest analysis for MasTec. The recent move to a US$264.99 share price comes after strong momentum, with a 7 day share price return of 12.55%, a 30 day gain of 18.46%, and a 1 year total shareholder return of 91.84%. These figures point to rising...

Healthcare Services Group (HCSG) has put a more upbeat marker down for FY 2025, with Q3 revenue of US$464.3 million and EPS of US$0.59, alongside net income of US$43.0 million. The company has seen revenue move from US$428.1 million in Q3 2024 to US$464.3 million in Q3 2025, while EPS shifted from US$0.19 to US$0.59 and net income from US$14.0 million to US$43.0 million. This sets up a story where leaner margins and an earnings track record sit at the center of how investors read this...

Clearway Energy (CWEN.A) has drawn investor interest with a recent share price near $37.33, along with a mix of revenue and net income trends that invites a closer look at how the business is currently positioned. See our latest analysis for Clearway Energy. At a share price of $37.33, Clearway Energy has seen firm short term momentum, with a 20.77% 1 month share price return and a 16.22% year to date share price return contributing to a 61.10% 1 year total shareholder return. This indicates...

If you are wondering whether Planet Labs PBC’s soaring share price still lines up with the underlying business, you are in the right place for a closer look at what that could mean for value. The stock has had a mixed recent run, with a 0.6% decline over the last 7 days and a 14.9% decline over the last 30 days, while still showing a 6.1% gain year to date and a 254.3% return over the last year, along with a 347.3% return over the last 3 years. These moves sit against a backdrop of ongoing...

Aflac reported its fourth-quarter and full-year 2025 results, with revenue of US$4,866 million and net income of US$1,379 million for the quarter, and full-year revenue of US$17.16 billion and net income of US$3.65 billion, both lower than the prior year. Despite these declines, management highlighted strong sales momentum in Japan driven by new cancer and medical products and resilient premium growth in the U.S., suggesting underlying demand for its supplemental insurance offerings remains...

Virtu Financial (VIRT) has drawn fresh attention after reporting full year 2025 results, with revenue of US$3,632.12 million, net income of US$468.36 million, and earnings per share more than doubling compared with the prior year. See our latest analysis for Virtu Financial. The latest results and dividend affirmation come after a strong run, with a 16.35% year to date share price return and a 3 year total shareholder return of 107.41%. This suggests momentum has been building over time,...

Wondering if Voya Financial at around US$75.29 is offering you good value right now, or if the easy money has already been made? The stock has had mixed recent returns, with a 3.5% gain over the last 7 days, a 3.6% decline over 30 days, and returns of 5.2% over 1 year, 4.8% over 3 years, and 47.0% over 5 years. Recent company updates, corporate actions, and industry headlines around diversified financials help explain why the share price has moved in different directions over the short and...

Insider buying focus after earnings setback W. R. Berkley (WRB) has drawn investor attention after major shareholder Mitsui Sumitomo Insurance committed about US$57 million to insider purchases following a 21.9% year over year decline in quarterly earnings. See our latest analysis for W. R. Berkley. At a share price of US$71.54, W. R. Berkley has seen a 1 day share price return of 2.32% and a 30 day share price return of 4.12%. Its 1 year total shareholder return of 20.93% and 5 year total...

Exact Sciences reports that more than 2 million breast cancer patients have now used its Oncotype DX Breast Recurrence Score test. The test is used to help personalize treatment decisions and reduce unnecessary chemotherapy in early stage breast cancer. This milestone highlights broad global adoption of the test in precision cancer care. For investors watching Exact Sciences, NasdaqCM:EXAS, this milestone sits alongside a current share price of $103.43. The stock has returned 105.5% over...

Colgate-Palmolive (CL) shares are in focus after fourth quarter results showed revenue ahead of analyst expectations. Management highlighted momentum in oral care and pet nutrition despite softer category conditions in several markets. See our latest analysis for Colgate-Palmolive. Those fourth quarter numbers and the 2026 outlook arrive after a strong run in the shares, with a 16.33% 1 month share price return and a 40.76% 3 year total shareholder return suggesting momentum has been building...

EZCORP (NasdaqGS:EZPW) announced a multi year US$50 million share repurchase program. The company highlighted an active M&A pipeline with a focus on expanding its pawn footprint across Latin America. Management pointed to available liquidity and an intent to remain disciplined on deal terms while pursuing further acquisitions. EZCORP runs pawn and related consumer financial services, a segment that tends to draw interest when credit conditions are tight and many customers look for small,...

ResMed stock snapshot after recent moves ResMed (RMD) has drawn attention after recent share price swings, with the stock closing at US$259.62. For context, the company reports annual revenue of US$5.40b and net income of US$1.49b. See our latest analysis for ResMed. Recent weakness, including a 1-day share price return of a 1.49% decline and a softer 7-day move, sits against a steadier backdrop. The year-to-date share price return of 6.05% alongside a 1-year total shareholder return of...